Cargando…

Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses

Detalles Bibliográficos
Autores principales: Anft, Moritz, Blazquez-Navarro, Arturo, Frahnert, Michael, Fricke, Lutz, Meister, Toni L., Roch, Toralf, Stervbo, Ulrik, Pfaender, Stephanie, Westhoff, Timm H., Babel, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107179/
https://www.ncbi.nlm.nih.gov/pubmed/35580654
http://dx.doi.org/10.1016/j.kint.2022.05.004
_version_ 1784708434565791744
author Anft, Moritz
Blazquez-Navarro, Arturo
Frahnert, Michael
Fricke, Lutz
Meister, Toni L.
Roch, Toralf
Stervbo, Ulrik
Pfaender, Stephanie
Westhoff, Timm H.
Babel, Nina
author_facet Anft, Moritz
Blazquez-Navarro, Arturo
Frahnert, Michael
Fricke, Lutz
Meister, Toni L.
Roch, Toralf
Stervbo, Ulrik
Pfaender, Stephanie
Westhoff, Timm H.
Babel, Nina
author_sort Anft, Moritz
collection PubMed
description
format Online
Article
Text
id pubmed-9107179
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-91071792022-05-16 Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses Anft, Moritz Blazquez-Navarro, Arturo Frahnert, Michael Fricke, Lutz Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-07 2022-05-14 /pmc/articles/PMC9107179/ /pubmed/35580654 http://dx.doi.org/10.1016/j.kint.2022.05.004 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Anft, Moritz
Blazquez-Navarro, Arturo
Frahnert, Michael
Fricke, Lutz
Meister, Toni L.
Roch, Toralf
Stervbo, Ulrik
Pfaender, Stephanie
Westhoff, Timm H.
Babel, Nina
Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
title Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
title_full Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
title_fullStr Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
title_full_unstemmed Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
title_short Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
title_sort inferior cellular and humoral immunity against omicron and delta variants of concern compared with sars-cov-2 wild type in hemodialysis patients immunized with 4 sars-cov-2 vaccine doses
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107179/
https://www.ncbi.nlm.nih.gov/pubmed/35580654
http://dx.doi.org/10.1016/j.kint.2022.05.004
work_keys_str_mv AT anftmoritz inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT blazqueznavarroarturo inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT frahnertmichael inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT frickelutz inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT meistertonil inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT rochtoralf inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT stervboulrik inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT pfaenderstephanie inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT westhofftimmh inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses
AT babelnina inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses